Aspirin dilemma: to stop or not in brain bleed patients?

NCT ID NCT07240454

First seen Nov 21, 2025 · Last updated May 14, 2026 · Updated 25 times

Summary

This study looks at whether people with a chronic subdural hematoma (a slow brain bleed) who take aspirin regularly should continue or stop it while receiving non-surgical treatment. Researchers will track if the bleed gets worse or comes back within 6 months. The goal is to provide clearer guidance on managing aspirin use to improve individual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tianjin Medical University General Hospital

    RECRUITING

    Tianjin, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xuanwu Hospital Capital Medical University

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.